Log In
Print
BCIQ
Print
Print this Print this
 

NicVax

  Manage Alerts
Collapse Summary General Information
Company Biota Pharmaceuticals Inc.
DescriptionNicotine conjugate vaccine
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase III
Standard IndicationAddiction
Indication DetailsPrevent nicotine dependence; Treat and prevent nicotine addiction and smoking relapse; Treat nicotine addiction and prevent smoking relapse
Regulatory Designation

U.S. - Special Protocol Assessment (Treat nicotine addiction and prevent smoking relapse)

Partner

GlaxoSmithKline plc


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today